Ignite Creation Date:
2024-05-06 @ 3:36 PM
Last Modification Date:
2024-10-26 @ 1:53 PM
Study NCT ID:
NCT04696731
Status:
RECRUITING
Last Update Posted:
2023-10-31
First Post:
2021-01-04
Brief Title:
Safety and Efficacy of ALLO-316 in Subjects With Advanced or Metastatic Clear Cell Renal Cell Carcinoma
Sponsor:
Allogene Therapeutics
Organization:
Allogene Therapeutics
Organization Data
Organization:
Allogene Therapeutics
Class:
INDUSTRY
Study ID:
ALLO-316-101
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Allogene Therapeutics
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None